Clinical Trials Logo

Social Anxiety clinical trials

View clinical trials related to Social Anxiety.

Filter by:

NCT ID: NCT05602012 Completed - Social Anxiety Clinical Trials

Mindfulness Based Cognitive Counseling on Social Anxiety

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to determine the effect of group mindfulness based cognitive counseling on social anxiety, assertiveness and self-confidence in nursing students and the relationship of these variables to change over time.

NCT ID: NCT05576259 Completed - Social Anxiety Clinical Trials

oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder

Start date: October 8, 2022
Phase: N/A
Study type: Interventional

Social anxiety is characterised by excessive fear of being negatively judged, embarrassed or humiliated during social interactions and is common with a lifetime prevalence of 12.1%. Cognitive behavioural therapy is the first line of treatment, but people may not seek treatment due to a number of factors including the discomfort experienced in seeking help, inconvenience, and the experience of psychotherapy itself. With Virtual Reality (VR), users can have increased control in how gradually they expose themselves to social situations. In studies of VR in people with specific phobias, 76% of people prefer VR exposure to in vivo exposure. There is emerging evidence for the use of VR in social phobia. oVRcome, is a self-help VRET for social anxiety symptoms and specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. This study will evaluate the effectiveness of the oVRcome social anxiety program for social anxiety symptoms. We hypothesize that oVRcome will reduce social anxiety symptom severity over a 6-week treatment period compared to waiting-list control

NCT ID: NCT05554718 Recruiting - Social Anxiety Clinical Trials

Evaluation of a Smartphone Application for Self-help for Social Anxiety

SMASH
Start date: October 2022
Phase: N/A
Study type: Interventional

The present study examines whether a self-help app can reduce symptoms of social anxiety disorder.

NCT ID: NCT05378711 Completed - Social Anxiety Clinical Trials

Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

Start date: January 1, 2014
Phase: Phase 2
Study type: Interventional

The Department of Counseling, Educational Psychology, and Special Education and the Department of Psychiatry at Michigan State University have coordinated efforts to provide a diagnostic and treatment investigation for children, ages seven to eighteen, with Selective Mutism. The purpose of this study is to examine the utility of fluoxetine for the treatment of this debilitating disorder. Fluoxetine is expected to improve social anxiety and selective mutism symptomology.

NCT ID: NCT05372744 Completed - Depression Clinical Trials

Affect-regulatory Characteristics of Deceptive Placebos

Start date: May 25, 2022
Phase: N/A
Study type: Interventional

The study tries to identify whether specifically framed expectations, induced with an active placebo nasal-spray, have effects on affective regulation processes and rumination.

NCT ID: NCT05302518 Active, not recruiting - Social Phobia Clinical Trials

Virtual Reality for AnxIety Disorders - Randomized Controlled Trial

VR8
Start date: March 31, 2022
Phase: N/A
Study type: Interventional

Social anxiety disorder (SAD) has a high prevalence and an early onset and has a lengthy recovery period often taking decades to occur. Current evidence supports the efficacy of cognitive behavioral therapy (CBT) with virtual reality (VR) exposure. However, the evidence is based on a small number of studies. This trial examines the efficacy of an intervention that combines CBT with individually tailored exposure in VR. During exposure, participants' anxiety level is estimated in real time based on heart rate and electrodermal activity. Estimated anxiety level can guide the therapist's adjustment of the VR content. The above treatment is compared with the gold standard treatment for SAD which is cognitive behavioral therapy with exposure conducted in real life. Treatment is individual, manual-based and consists of 10 weekly sessions with a duration of 60 minutes. The aim of the study is to investigate whether CBT combined with exposure in VR (adapted on the basis of estimated anxiety level) is more effective than CBT with exposure in real life. The trial is a randomized controlled trail (RCT). The study includes 90 participants diagnosed with SAD. Assessments are carried out pre-treatment, mid-treatment and at follow-up (6 and 12 months). The primary outcome of the study is self-reported symptoms of social anxiety using Social Interaction Anxiety Scale. The primary endpoint is post-treatment.

NCT ID: NCT05292807 Recruiting - Social Anxiety Clinical Trials

Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms

Start date: April 14, 2022
Phase: N/A
Study type: Interventional

This study will recruit 460 participants who self-report high symptoms of anxiety. Participants will be randomly assigned to one of 4 groups: one analog intervention of Imagery Rescripting (IR) for memories, an analog intervention of IR for future events, and analog intervention of Imaginal Exposure (IE) for memories and an analog intervention of IE for future events. We will examine the efficacy and mechanisms behind each intervention.

NCT ID: NCT05168020 Completed - Social Anxiety Clinical Trials

Evaluation of a Self-Monitoring Intervention to Reduce Safety Behavior in Social Anxiety

Start date: September 28, 2021
Phase: N/A
Study type: Interventional

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

NCT ID: NCT05159037 Completed - Social Anxiety Clinical Trials

Using the Musical Track From GC-MRT as a Treatment Booster in Stressful Situations

Start date: November 7, 2021
Phase: N/A
Study type: Interventional

The study examines whether musical tracks played during gaze contingent music reward therapy (GC-MRT) for social anxiety could later be used as a booster to reduce anxiety before a stressful situation. To this end, highly socially anxious participants will undergo 4 GC-MRT sessions designed to train participants' attention away from threat and towards neutral social stimuli. Subsequently, participants will be asked to perform a socially stressful speech task. Prior to the speech, half of the participants will listen to a musical track the participants were trained with, and half of the participants will listen to a musical track the participants like but were not trained with during the GC-MRT sessions. The investigators expect that listening to musical track taken from the GC-MRT sessions will moderate the increase in anxiety levels prior to the speech and will improve performance during the speech compared to a non-trained musical track.

NCT ID: NCT05018260 Completed - Clinical trials for Social Anxiety Disorder

Attention Bias Modification Versus Attention Control in Treatment of Social Anxiety

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the clinical efficacy of treatment using gaze contingent music reward therapy (GC-MRT) with attention control treatment based on a similar paradigm, for social anxiety disorder (SAD)